2018. PHARMACOLOGIC TOPOISOMERASE-I INHIBITION CAUSES DNA DAMAGE AND MORTALITY IN ACTIVATED CD4+ T CELLS. Genetics & Applications. 2, 2 (Dec. 2018), 51–56. DOI:https://doi.org/10.31383/ga.vol2iss2pp51-56.